Skip to main content

CITIGROUP INC

Position in PCRX — Pacira BioSciences, Inc.

CIK 831001 NEW YORK, NY

Position in PCRX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$903,450
+$245,406 QoQ
Shares Held
35,611
+22.3% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#95
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Derivatives in PCRX

reported options exposure · as of Mar 31, 2020
CallValue
$20,118
CallShares
600
PutValue
$6,706
PutShares
200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. PCRX ranks #29 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCRX

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $903,450 35,611
2026-03-31 $658,044 29,117
2025-12-31 $904,298 34,942
2025-09-30 $793,585 30,795
2025-06-30 $1,253,123 52,432
2025-03-31 $2,110,657 84,936
2024-12-31 $1,461,210 77,559
2024-09-30 $1,363,363 90,589
2024-06-30 $1,195,981 41,803
2024-03-31 $1,111,030 38,023
2023-12-31 $1,319,874 39,119
2023-09-30 $1,630,977 53,161
2023-06-30 $1,742,762 43,493
2023-03-31 $1,150,513 28,192
2022-12-31 $1,261,040 32,661
2022-09-30 $1,548,890 29,120
2022-06-30 $1,660,440 28,481
2022-03-31 $3,785,623 49,602
2021-12-31 $2,691,042 44,724
2021-09-30 $3,361,120 60,020
2021-06-30 $3,018,829 49,750
2021-03-31 $1,805,166 25,755
2020-12-31 $2,178,773 36,410
2020-09-30 $1,863,598 30,998
2020-06-30 $2,442,109 46,543
2020-03-31 $6,706 200
2020-03-31 $1,058,306 31,563
2020-03-31 $20,118 600